Current Status and Challenges in Jcog Data Center (DC) And Operations Office (OPS)

Nakamura, Keiko; Fukuda, Haruhiko; Shibata, T; Kaba, Hani E.J.; Takashima, A.; Tomii, Yasushi; Murooka, A.; Toshima, Hiroaki; Abe, Jun‐ichi; Katayama, Hokahiro; Kunieda, Futoshi; Kimura, Akihiko; Kanato, Keisuke; Mizusawa, Junki; Yamashita, Naohide; Takeda, Kazuya; Matsuura, Naohiro; Takiguchi, Yuichi; Sakaida, Emiko; Sekine, Ikuo; Minami, Hironobu; Tamura, Kenji; Fujiwara, Yutaka; Hirohashi, Takeshi; Hashimoto, Jonathan; Yamaji, Satoshi; Uchida, Hideo; Mori, Shoko; Shi, Xiaodong; Kameo, Satomi; Aono, Hiroshi; Aogi, K.; Ando, Yuichi; Yonemori, Kan; Shimizu, Tadafumi; Okamoto, Ikumi; Kurata, Takako; Fujisaka, Y.; Tsurutani, J.; Nomura, Morihiro; Minami, Taro; Sakaguchi, Kenjiro; Ohnishi, R.; Chang, Joon-Shik; Hase, Yoichi; Nakagawa, Kazuhiko; Yamamoto, S; Saji, Shigehira; Sato, Fumie; Kinoshita, Tsuyoshi; Tomita, Akira; Obi, Shawn; Sato, Sayaka; Satō, Takashi; Kawai, Tadashi; Kanda, M. B.; Okusaka, Takushi; Cheng, Aaron; Kudo, Masatoshi; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Morita, Rena; Nishizawa, Satoshi; Takahashi, Akiko; Inoda, Satoko; Hara, Ichirô; Sato, Noriyuki; Daigo, Yataro; Yamaue, Hiroki; Miyazawa, Motoki; Mizuno, Naoko; Fukutomi, Akira; Ishii, Henrique Akira; Ohkawa, Shuji; Furukawa, Michael F.; Maguchi, H.; Ikeda, Masayuki; Nishio, Kazuto; Ohashi, Yasuo; Tsunoda, Tsukasa; Sugiyama, Hidenori; Noguchi, Masanori; Suekane, Shigetaka; Moriya, Fukuko; Sasada, Tetsuro; Yamada, Akira; Itoh, Kyogo; Suzuki, Kozue; Baba, Eishi; Kusaba, H.; Takaishi, S.; Akashi, Katsuya; Takano, Toshimi; Nakajima, Takako Eguchi; Yamamoto, Nobuyuki; Tateishi, U.; Yamada, Yasuhiko; Iwata, Hirotoshi; Kuwata, Tomoyuki; Yamaguchi, Kojiro; Ooki, A.; Yamada, Tomoko; Hara, H.; Asayama, Masami; Tada, Miho; Hamamoto, Yuki; Funakoshi, S.; Higuchi, Hitomi; Takaishi, Hiroyuki; Hibi, Toshifumi; Maruyama, Dai; Tobinai, Kensei; Nishida, Tomoko; Yano, Seiji; Soda, Manabu; Mano, Hiroyuki; Mukohara, Toru; Morita, Tatsuya; Akechi, Tatsuo; Maruguchi, Misae; Takahashi, M.; Takayama, Tsuyoshi; Yatabe, Yasushi; Jänne, Pasi A.; Sasaki, Takaaki; Ohsaki, Yoshinobu; Pasi, John; Aoki, Yasuchika; Nishiuma, S.; Kikkawa, Tomonobu; Tahara, Masao

doi:10.1093/annonc/mds570

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Outside of the US, several groups in Europe and Asia have proton therapy protocols open or in development. The Japan Clinical Oncology Group (JCOG) is funded by Japan's National Cancer Center Research and Development Fund and conducts studies with proton therapy [8]. The European Organization for Research and Treatment of Cancer (EORTC) operates clinical trials within Europe and currently has two protocols with proton therapy embedded [9] Therapy Network (EPTN), which conducts a number of prospective studies looking at proton (and carbon) therapy, and works in concert with the EORTC [10,11].…”

Section: Clinical Trial Groupsmentioning

confidence: 99%

Clinical Trials Evaluating Proton Therapy

Taylor¹

2021

Proton Therapy - Current Status and Future Directions

View full text Add to dashboard Cite

Although proton therapy was developed almost 80 years ago, widespread clinical implementation has been limited until the past decade. With the growing use of proton therapy, there is a desire to prove the equivalence or superiority of proton therapy across a number of cancer disease sites. Dozens of clinical trials have been developed to accomplish this within individual institutions, among a few centers, and across national and international networks such as the National Cancer Institute’s National Clinical Trial Network. The protocols include proton therapy imbedded in trials with photon therapy as well as randomized photon vs. proton trials. This chapter provides an overview of the design of such trials as well as some of the challenges facing protocols with proton therapy.

show abstract

Section: Clinical Trial Groupsmentioning

confidence: 99%

Clinical Trials Evaluating Proton Therapy

Taylor¹

2021

Proton Therapy - Current Status and Future Directions

View full text Add to dashboard Cite

show abstract

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

Hershman

Lacchetti

Dworkin

et al. 2014

JCO

1,038

734

View full text Add to dashboard Cite

On the basis of the paucity of high-quality, consistent evidence, there are no agents recommended for the prevention of CIPN. With regard to the treatment of existing CIPN, the best available data support a moderate recommendation for treatment with duloxetine. Although the CIPN trials are inconclusive regarding tricyclic antidepressants (such as nortriptyline), gabapentin, and a compounded topical gel containing baclofen, amitriptyline HCL, and ketamine, these agents may be offered on the basis of data supporting their utility in other neuropathic pain conditions given the limited other CIPN treatment options. Further research on these agents is warranted.

show abstract

Current Status and Challenges in Jcog Data Center (DC) And Operations Office (OPS)

Cited by 2 publications

References 0 publications

Clinical Trials Evaluating Proton Therapy

Clinical Trials Evaluating Proton Therapy

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

Contact Info

Product

Resources

About